Albemarle (NYSE: ALB) has recently received a number of price target changes and ratings updates:
- 7/5/2026 – Albemarle was downgraded by Wall Street Zen from “strong-buy” to “buy”.
- 7/1/2026 – Albemarle had its price target lowered by Rothschild & Co Redburn from $188.00 to $170.00. They now have a “neutral” rating on the stock.
- 7/1/2026 – Albemarle had its price target lowered by Mizuho from $205.00 to $185.00. They now have a “neutral” rating on the stock.
- 6/30/2026 – Albemarle had its price target lowered by Jefferies Financial Group Inc. from $244.00 to $211.00. They now have a “buy” rating on the stock.
- 6/27/2026 – Albemarle was upgraded by Wall Street Zen from “buy” to “strong-buy”.
- 6/18/2026 – Albemarle was upgraded by Citigroup Inc. from “neutral” to “buy”. They now have a $225.00 price target on the stock.
- 6/18/2026 – Albemarle had its price target lowered by Robert W. Baird from $236.00 to $224.00. They now have a “neutral” rating on the stock.
- 6/13/2026 – Albemarle was downgraded by Wall Street Zen from “strong-buy” to “buy”.
- 6/2/2026 – Albemarle had its price target raised by Berenberg Bank from $153.00 to $192.00. They now have a “hold” rating on the stock.
- 5/26/2026 – Albemarle had its price target raised by Royal Bank Of Canada from $253.00 to $257.00. They now have an “outperform” rating on the stock.
- 5/26/2026 – Albemarle was upgraded by Vertical Research from “hold” to “buy”. They now have a $224.00 price target on the stock.
- 5/23/2026 – Albemarle was upgraded by Wall Street Zen from “buy” to “strong-buy”.
- 5/14/2026 – Albemarle had its price target raised by Scotiabank from $200.00 to $215.00. They now have an “outperform” rating on the stock.
- 5/13/2026 – Albemarle had its price target raised by Scotiabank from $200.00 to $215.00. They now have a “sector outperform” rating on the stock.
- 5/12/2026 – Albemarle had its price target raised by Deutsche Bank Aktiengesellschaft from $210.00 to $250.00. They now have a “buy” rating on the stock.
- 5/11/2026 – Albemarle was upgraded by Zacks Research from “hold” to “strong-buy”.
- 5/11/2026 – Albemarle had its price target raised by Royal Bank Of Canada from $245.00 to $253.00. They now have an “outperform” rating on the stock.
- 5/11/2026 – Albemarle had its price target raised by Argus from $185.00 to $230.00. They now have a “buy” rating on the stock.
- 5/11/2026 – Albemarle had its price target raised by Jefferies Financial Group Inc. from $230.00 to $244.00.
- 5/9/2026 – Albemarle was upgraded by Wall Street Zen from “hold” to “buy”.
- 5/8/2026 – Albemarle had its price target raised by UBS Group AG from $230.00 to $264.00. They now have a “buy” rating on the stock.
- 5/8/2026 – Albemarle had its price target raised by Truist Financial Corporation from $245.00 to $260.00. They now have a “buy” rating on the stock.
- 5/8/2026 – Albemarle had its price target raised by Citigroup Inc. from $210.00 to $225.00. They now have a “neutral” rating on the stock.
- 5/8/2026 – Albemarle had its price target raised by Wells Fargo & Company from $165.00 to $200.00. They now have an “equal weight” rating on the stock.
Albemarle Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 1st. Shareholders of record on Friday, June 12th were paid a $0.405 dividend. The ex-dividend date of this dividend was Friday, June 12th. This represents a $1.62 dividend on an annualized basis and a yield of 1.3%. Albemarle’s dividend payout ratio (DPR) is presently -47.51%.
Insider Buying and Selling
In related news, CEO J Kent Masters sold 16,393 shares of the stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $183.72, for a total value of $3,011,721.96. Following the sale, the chief executive officer directly owned 87,519 shares in the company, valued at $16,078,990.68. This trade represents a 15.78% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.42% of the company’s stock.
Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.
Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.
Featured Articles
- Five stocks we like better than Albemarle
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
